Johnson & Johnson posted its third quarter financial results this week revealing a beat and also raised its full-year guidance. The multinational corporation giant also revealed that it had paused its final-phase Covid-19 vaccine testing, including its key Phase 3 clinical trials. The move came after an unexplained illness of one participant. As per its … Continue reading “Johnson & Johnson Beats in Q3 But Pauses Covid-19 Vaccines Tests”
